Letter: monoclonal gammopathy of HEV infection. When is it significant? – Authors’ reply

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|10|1028-1028

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.10, 2015-05, pp. : 1028-1028

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: monoclonal gammopathy of HEV infection. When is it significant?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 10, 2015-05 ,pp. : 1027-1028

John Wiley & Sons Inc

Access to resources Recommend Favorite

Authors' reply to letter by C. Steffen

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 7, 2015-08 ,pp. : 1051-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: mucosal response in discriminating intestinal tuberculosis from Crohn's disease—when to look for it? Authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 860-861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 8, 2015-10 ,pp. : 1031-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 8, 2015-10 ,pp. : 1031-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite